SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001325310-08-000038
Filing Date
2008-05-09
Accepted
2008-05-09 17:10:31
Documents
9
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 JUNE 30, 2007 20F alda20f2007.htm 20-F 779334
2 JUNE 30, 2007 20F PDF FORMAT alda20f2007.pdf GRAPHIC 843008
3 CEO AND CFO CERTIFICATES PURSUANT TO SECTION 906 OF SARBANES-OXLEY ACT OF 2002 aldacertssection906.htm EX-99.CERT 5852
4 CEO AND CFO CERTIFICATES PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002 aldacertssection302.htm EX-99.CERT 11257
5 alda20f2007006.jpg GRAPHIC 34097
6 alda20f2007002.gif GRAPHIC 25550
7 alda20f2007003.jpg GRAPHIC 3959
8 alda20f2007004.jpg GRAPHIC 8843
9 alda20f2007005.jpg GRAPHIC 40420
  Complete submission text file 0001325310-08-000038.txt   2115696
Mailing Address 635 COLUMBIA STREET VANCOUVER A1 V6E1T9
Business Address 635 COLUMBIA STREET VANCOUVER A1 V6E1T9 6045218300
ALDA Pharmaceuticals Corp. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-51848 | Film No.: 08819585
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1